Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis.

BACKGROUND: Non-small cell lung cancer (NSCLC) is the most common form of lung cancer. Some epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutations make tumours responsive to treatment with EGFR-TK inhibitors (EGFR-TKIs) but less responsive to treatment with standard chemotherapy. Patie...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Health Technol Assess
Main Authors: Westwood, Marie, Joore, Manuela, Whiting, Penny, van Asselt, Thea, Ramaekers, Bram, Armstrong, Nigel, Misso, Kate, Severens, Johan, Kleijnen, Jos
Formato: Artigo
Idioma:Inglês
Publicado: NIHR Journals Library 2014
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4781337/
https://ncbi.nlm.nih.gov/pubmed/24827857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta18320
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares